Baird Medical Investment Holdings Limited

10-Year Study

BDMD.US · Healthcare · US · Common Stock

Executive Summary: Baird Medical Investment Holdings Limited has compounded at -69.4% annually over the last 10 years, with a maximum drawdown of 91.1% and an annualized volatility of 2816.4%.

1Y CAGR
-57.9%
3Y CAGR
-69.4%
5Y CAGR
-69.4%
10Y CAGR
-69.4%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
91.1%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.46
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
1.63
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
256.1%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · +27.9%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · -82.1%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
50%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
2026-26.5198.0-34.2-11.2————————27.9%
2025-6.7-42.527.710.4-33.0-4.8-44.320.1-13.5-38.212.2-7.5-82.1%
2024—————————-75.9-9.9210.2-32.7%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 2816.4%. The dominant macroeconomic risk driver is SHV.US, accounting for 91.9% of variance. Idiosyncratic stock-specific factors contribute 0.1%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2024-09-0110000
2024-10-012409.211691762622
2024-11-012170.0620017714796
2024-12-016731.620903454385
2025-01-016279.893711248893
2025-02-013613.817537643933
2025-03-014614.703277236493
2025-04-015093.002657218778
2025-05-013410.097431355182
2025-06-013246.2356067316214
2025-07-011806.9087688219665
2025-08-012170.0620017714796
2025-09-011877.7679362267497
2025-10-011160.3188662533216
2025-11-011302.0372010628876
2025-12-011204.605845881311
2026-01-01885.7395925597874
2026-02-012639.5039858281666
2026-03-011736.0496014171833
2026-04-011541.1868910540302
Annual Return Matrix
YearAnnual Return
2025-0.8210526315789474
20260.27941176470588225
Total Factor Risk
28.164463664718685
VTI.US Exposure
0.027665701186226892
VEA.US Exposure
0.0032248657235301177
VWO.US Exposure
-0.0002436509864279262
QQQ.US Exposure
0.0085778885519407
VTV.US Exposure
0.0019052917370104858
IJR.US Exposure
-0.0016605375315070004
QUAL.US Exposure
0.005058962949825456
SHV.US Exposure
0.919450915785492
TLT.US Exposure
0.002066257484112229
LQD.US Exposure
0.007960862799419396
HYG.US Exposure
0.004922181021077028
GLD.US Exposure
0.003038337043200958
USO.US Exposure
0.005034562784365857
VNQ.US Exposure
0.003551119249428204
BTC-USD.CC Exposure
-0.00042701470910561085
CPER.US Exposure
0.00035283356402609226
VIX.INDX Exposure
0.00018448030725415508
UUP.US Exposure
0.0005840615145810635
TIP.US Exposure
0.00821115914352634
Idiosyncratic Exposure
0.0005417223820237243
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
2816.4%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$71.6M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-9.7%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-8.3%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
75.5% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
-1.16
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is Baird Medical Investment Holdings Limited a high-risk investment?

Baird Medical Investment Holdings Limited (BDMD.US) has an annualized volatility of 2816.4% and experienced a maximum drawdown of 91.1% over the last 10 years. Its primary macro risk driver is SHV.US.

What is the 10-year return of BDMD.US?

Over the past 10 years, BDMD.US has generated a Compound Annual Growth Rate (CAGR) of -69.4%. It has had a positive return in 50% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Baird Medical Investment Holdings Limited

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest